1 Introduction 12
1.1 Industry Definition and Research Scope 12
1.1.1 Industry Definition 12
1.1.2 Research Scope 13
1.2 Research Methodology 16
1.2.1 Overview of Market Research Methodology 16
1.2.2 Market Assumption 17
1.2.3 Secondary Data 17
1.2.4 Primary Data 17
1.2.5 Data Filtration and Model Design 18
1.2.6 Market Size/Share Estimation 19
1.2.7 Research Limitations 20
1.3 Executive Summary 21
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 33
2.3 Market Restraints and Challenges 41
2.4 Emerging Opportunities and Market Trends 44
2.5 Porters Fiver Forces Analysis 48
3 Segmentation of Global Market by Synthesis 52
3.1 Market Overview by Synthesis 52
3.2 Synthetic API 54
3.2.1 Branded Synthetic API 55
3.2.2 Generic Synthetic API 56
3.3 Biotech API 57
3.3.1 Biotech API by Drug Type 58
3.3.1.1 Monoclonal Antibodies 59
3.3.1.2 Recombinant Proteins 60
3.3.1.3 Vaccines 61
3.3.1.4 Other Biotech APIs 62
3.3.2 Biotech API by Category 63
3.3.2.1 Innovative Biologic API 64
3.3.2.2 Generic Biosimilar API 65
3.3.3 Biotech API by Expression Technology 66
3.3.3.1 Mammalian Expression 67
3.3.3.2 Microbial Expression 68
3.3.3.3 Yeast Expression 69
3.3.3.4 Insect Expression 70
3.3.3.5 Other Expression Technologies 71
3.4 HPAPI 72
3.4.1 Branded HPAPI 73
3.4.2 Generic HPAPI 74
4 Segmentation of Global Market by Manufacturing Process 75
4.1 Market Overview by Manufacturing Process 75
4.2 Captive Manufacturing 77
4.2.1 Branded Captive API 78
4.2.2 Generic Captive API 79
4.3 Merchant Manufacturing 80
4.3.1 Merchant Manufacturing by Drug Type 81
4.3.1.1 Branded Merchant API 82
4.3.1.2 Generic Merchant API 83
4.3.2 Merchant Manufacturing by Drug Synthesis 84
4.3.2.1 Merchant Synthetic API 85
4.3.2.2 Merchant Biotech API 86
5 Segmentation of Global Market by Therapeutic Application 87
5.1 Market Overview by Therapeutic Application 87
5.2 Infectious Diseases 89
5.3 Oncology 90
5.4 Ophthalmology 91
5.5 Cardiovascular Disorders 92
5.6 Central Nervous System 93
5.7 Pulmonary Disorders 94
5.8 Orthopedics 95
5.9 Other Applications 96
6 Segmentation of Global Market by Drug Type 97
6.1 Market Overview by Drug Type 97
6.2 Branded Prescription Drugs 99
6.3 Generic Prescription Drugs 100
6.4 OTC Drugs 101
7 Segmentation of Global Market by Region 102
7.1 Geographic Market Overview 2021-2028 102
7.2 North America Market 2021-2028 by Country 107
7.2.1 Overview of North America Market 107
7.2.2 U.S. 110
7.2.3 Canada 121
7.2.4 Mexico 123
7.3 European Market 2021-2028 by Country 125
7.3.1 Overview of European Market 125
7.3.2 UK 128
7.3.3 France 130
7.3.4 Germany 132
7.3.5 Spain 134
7.3.6 Italy 136
7.3.7 Russia 138
7.3.8 Rest of European Market 140
7.4 Asia-Pacific Market 2021-2028 by Country 142
7.4.1 Overview of Asia-Pacific Market 142
7.4.2 China 145
7.4.3 Japan 147
7.4.4 India 150
7.4.5 Australia 152
7.4.6 South Korea 154
7.4.7 Rest of APAC Region 156
7.5 South America Market 2021-2028 by Country 158
7.5.1 Argentina 161
7.5.2 Brazil 163
7.5.3 Chile 165
7.5.4 Rest of South America Market 167
7.6 Rest of World Market 2021-2028 by Country 168
7.6.1 UAE 171
7.6.2 Saudi Arabia 173
7.6.3 South Africa 175
7.6.4 Other National Markets 177
8 Competitive Landscape 178
8.1 Overview of Key Vendors 178
8.2 New Product Launch, Partnership, Investment, and M&A 181
8.3 Company Profiles 182
AbbVie Inc. 182
Astrazeneca 184
Aurobindo Pharma Ltd. 189
BASF 192
Bayer AG 195
Boehringer Ingelheim 199
Catalent Inc. 204
Dr. Reddy's Laboratories 207
F. Hoffmann-La Roche 209
GlaxoSmithKline plc 211
Lonza Group 216
Lupin Limited 221
Merck & Co., Inc. 224
Mylan NV 227
Novartis International AG 230
Pfizer Inc. 233
Sanofi 238
Sun Pharmaceutical Industries Ltd. 241
Teva Pharmaceutical Industries Ltd. 244
Thermo Fisher Scientific 246
9 Investing in Global Market: Risk Assessment and Management 248
9.1 Risk Evaluation of Global Market 248
9.2 Critical Success Factors (CSFs) 251
Related Reports and Products 254